bluebird bio, Inc.
DONOR REPAIR TEMPLATES MULTIPLEX GENOME EDITING

Last updated:

Abstract:

The present disclosure provides improved multiplex genome editing compositions and methods. The disclosure further provides genome edited cells for the prevention, treatment, or amelioration of at least one symptom of a hemoglobinopathy, a cancer, an infectious disease, an autoimmune disease, an inflammatory disease, or an immunodeficiency.

Status:
Application
Type:

Utility

Filling date:

15 Feb 2018

Issue date:

26 Dec 2019